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Morning coffee is a common remedy following disrupted sleep yet each factor can independently 51 
impair glucose tolerance and insulin sensitivity in healthy adults. Remarkably, the combined effects 52 
of sleep fragmentation and coffee on glucose control upon waking per se have never been 53 
investigated. 54 
In a randomised cross-over design, 29 adults (Mean ± SD; age: 21 ± 1 years, BMI: 24.4 ± 3.3 kg·m-55 
2) underwent three oral glucose tolerance tests (OGTT). One following a habitual night of sleep 56 
(Control; in bed, lights-off trying to sleep ~2300-0700 h) the others following a night of sleep 57 
fragmentation (as Control but waking hourly for 5 min), once with and once without morning coffee 58 
~1 h after waking (~300 mg caffeine as black coffee 30 min prior to OGTT).  59 
Peak plasma glucose and insulin concentrations were unaffected by sleep quality but were higher 60 
following coffee consumption  (Mean [normalised confidence interval] for Control, Fragmented, and 61 
Fragmented+Coffee, respectively; Glucose: 8.20 [7.93-8.47] mmol∙L-1 versus 8.23 [7.96-8.50] 62 
mmol∙L-1 versus 8.96 [8.70-9.22] mmol.L-1; Insulin: 265 [247-283] pmol∙L-1; and 235 [218-253] 63 
pmol∙L-1; and 310 [284-337] pmol∙L-1). Likewise, iAUC for plasma glucose was higher in the 64 
Fragmented+Coffee trial compared to Fragmented. 65 
Whilst sleep fragmentation did not alter glycaemic or insulinaemic responses to morning glucose 66 




























Sleep curtailment is a risk factor for obesity-associated metabolic diseases, possibly due to the 93 
important role of sleep in maintaining glucose homeostasis [1]. For example, impaired glucose 94 
clearance and whole-body insulin sensitivity can occur following a single night of either sleep 95 
deprivation (e.g. limiting the habitual duration), broken sleep (i.e. 2 periods of sleep separated by an 96 
extended waking interval - e.g. 2300-0100 h & 0500-0730 h), or nonspecific sleep-fragmentation 97 
(e.g. random arousal stimuli throughout the night) [2-5]. Studies to date have employed differing 98 
protocols to curtail sleep however, to our knowledge, only one previous study has examined the 99 
influence of hourly sleep-fragmentation on postprandial metabolism [6]. In this study, postprandial 100 
insulin was lower following breakfast in the fragmentation condition relative to a normal night of 101 
sleep. However, whilst the use of metabolic units used in this study allowed for a highly controlled 102 
situation in which subjects are in a stable environment, it is important to consider the first night effect 103 
of an unfamiliar environment on sleep quality [7], and therefore to see whether these findings translate 104 
into more ecologically valid contexts (i.e. participants sleep in their own beds).  105 
 106 
From an ecological standpoint, coffee is a commonly used means of combatting feelings of lethargy 107 
and fatigue [8], therefore acting as a ‘therapeutic tool’ following disrupted sleep. However, whilst 108 
moderate habitual caffeinated coffee consumption is associated with reduced risk of cardiovascular 109 
mortality and cancer incidences [9], studies by Moisey et al Moisey, Robinson [10] (~62 mg caffeine 110 
per 100 mL coffee) and Robertson et al Robertson, Clifford [11] (100-400 mg caffeine) demonstrate 111 
the potential for a single serving of caffeinated coffee to acutely impair postprandial glucose 112 
metabolism in both normal-weight and overweight individuals. This raises the possibility that that 113 
coffee consumption could potentiate any negative effects of sleep disruption on glucose metabolism. 114 
Furthermore, this effect of caffeine upon postprandial glycaemia seems to be modulated by a single 115 
nucleotide polymorphism in the CYP1A2 gene, which codes for an enzyme responsible for caffeine 116 
metabolism in the liver [12]. Caffeine is primarily metabolised (>95%) through CYP1A2 activity 117 
[13]. However, this modulating role has yet to be investigated under a variety of scenarios [14, 15].  118 
 119 
It is remarkable therefore that no study to date has investigated their combined effects upon waking, 120 
although one study has investigated the combined influence of caffeinated coffee (65 mg caffeine) 121 
prior to sleep deprivation on next-day glucose control. Higher fasting serum insulin and increased 122 
levels of glucose and insulin were observed after an oral glucose tolerance test (OGTT) following 123 
sleep deprivation (4 h in bed) with consumption of caffeinated coffee relative to decaffeinated coffee 124 
[16]. However, coffee was consumed prior to sleep, which is not an ecologically valid model of when 125 
coffee is usually consumed, especially as a remedy following disrupted sleep. In addition, caffeine is 126 
4 
 
a fast-acting pharmacological agent, with metabolic effects that occur rapidly and may subside within 127 
hours (especially amongst habitual caffeine consumers; [17]), so there is also a clear physiological 128 
rationale to examine the acute effects of caffeine intake upon waking immediately prior to the first 129 
intake of nutrients following the overnight fast.  130 
 131 
The aim of this study, therefore, was to determine the effects of one night of sleep fragmentation with 132 
and without morning caffeinated coffee on glycaemic control relative to an undisturbed night of sleep 133 
in healthy young adults. An exploratory aim of the study was to examine whether individual responses 134 
were mediated by the CYP1A2 genotype of participants. It was hypothesised that sleep fragmentation 135 
per se would impair insulin sensitivity and that morning coffee would exacerbate this response, with 136 
the latter effect modulated by the relevant polymorphism of CYP1A2. 137 
 138 
Methods and Materials 139 
Participants 140 
Twenty-nine healthy men and women (Age: 21 ± 1 years, BMI: 24.4 ± 3.3 kg·m-2) participated in the 141 
study. Exclusion criteria included, body mass index outside of the range of 18.5-29.9 kg∙m-2, any 142 
diagnosed metabolic disease (e.g. type 1 or type 2 diabetes), reported use of substances which may 143 
pose undue personal risk to the participants or introduce bias into the experiment, and non-standard 144 
sleep-wake cycle (e.g. shift worker). All were informed of any potential risks and discomfort involved 145 
in the study prior to providing written and oral informed consent. The study was given a favourable 146 
ethical opinion by the Research Ethics Approval Committee for Health (REACH) at the University 147 
of Bath (SES/HES: 18R1-019). The measurements of CY1PA2 gene polymorphism were completed 148 
as part of a wider screening project for which ethical approval was granted by the National Health 149 
Service Research Ethics Committee (18/NW/0573). All procedures were performed in accordance 150 
with the Declaration of Helsinki.  151 
Experimental Design 152 
Participants underwent three trials in a randomised cross-over design, with a washout interval of 7-153 
14 days. For 48 h prior to each trial, participants standardised diet and physical activity and refrained 154 
from consuming caffeine and alcohol. Main trials involved an oral glucose tolerance test (OGTT) 155 
following a habitual night of sleep (Control; in bed, lights-off trying to sleep 8 consecutive hours, 156 
waking <1 hour prior to arrival at the lab) and a night of sleep fragmentation (Fragmented; as control 157 
but waking hourly for 5 min – prompted and verified by repeated text messaging), with and without 158 
morning coffee (Fragmented+Coffee; 300 mg caffeine as black coffee 30 min prior to OGTT).  159 
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Experimental Protocol 160 
Participants arrived in the laboratory at between 0800 h and 1000 h (within 1-hour of waking) in an 161 
overnighted fasted state (~10 h). Height, body mass, waist:hip circumference were assessed before 162 
participants completed baseline subjective assessments of sleep quality, mood, and appetite on a 0-163 
100 mm scale. Waist and hip circumferences were measured using a tape measure around the mid-164 
point between bottom rib and top of the iliac crest and at the largest circumference between the waist 165 
and thighs respectively [18]. An intravenous cannula was placed into an antecubital vein and a 166 
baseline sample of 5 mL venous blood collected (BD Venflon Pro; BD, Eysins, Switzerland). 167 
Cannulae were kept patent throughout all trials by flushing with 0.9% NaCl infusion (B. Braun; 168 
Sheffield, UK). Participants would then either consume a cup of caffeinated coffee (8.8 g Nescafé 169 
Original, Nestlé, SUI with 300 mL water; ~300 mg caffeine, ~163 mg total caffeoylquinic acids) or 170 
a matched volume of hot water over a 10-min period, 30-minutes prior to undergoing an OGTT. At 171 
the end of this 30-minute period a 5 mL blood sample was obtained before ingesting a 75 g oral load 172 
of glucose (113 mL Polycal; Nutricia, UK with 87 mL water). Further blood samples were then taken 173 
at 15- and 30-minute intervals for the first and second hour of the protocol respectively, alongside 174 
hourly assessments of subjective mood and appetite.  175 
Sleep Fragmentation 176 
Participants were asked to achieve 8-h time in bed, trying to sleep (~2300-0700 h –modifiable 177 
according to individual preference and time of testing the next day). Audible alarms were set on the 178 
hour every hour throughout the night. Upon waking, participants would receive a series of 10 text 179 
messages from a member of the research team, at a rate of 1 every 30 seconds, which required simple 180 
responses prior to being able to fall asleep again (e.g. simple arithmetic). This would be repeated until 181 
wake time. Participants rated subjective sleep fragmentation using visual analogue scales upon 182 
entering the laboratory.  183 
Blood analysis 184 
All blood samples were immediately transferred into tubes treated with ethylenediaminetetraacetic 185 
acid (EDTA) prior to centrifugation (10 min, 4000 x g, 4C) before the plasma supernatant was 186 
aliquoted and stored at -80C for subsequent metabolite analysis. In the control trial the buffy coat 187 
layer of the centrifuged bloods was removed and stored at -80C for later genetic profiling. All plasma 188 
samples were later analysed for plasma glucose, using a spectrophotometric analyser (RX, Daytona, 189 
Randox Laboratories Ltd., Crumlin, UK; Inter-assay CV: <2 %) and insulin via enzyme-linked 190 
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immunosorbent assay (ELISA; Crystal Chem, IL, USA; Inter-assay CV: 13 ± 3%, Intra-assay CV: 6 191 
± 2%). 192 
DNA extraction and analysis 193 
DNA was extracted from the buffy coat layer using QIAamp DNA Blood Mini Kit following 194 
manufacturer’s instructions (Qiagen, Germany) and frozen at -80°C until analysis. Extracted DNA 195 
was then analysed for the rs762551 SNP using a 5'-nuclease allelic discrimination assay (Taqman 196 
drug metabolism genotyping assay SNP ID rs762551, C___8881221_40 [C/A], gene CYP1A2; 197 
ThermoFisher Scientific, US). 198 
Statistical Analysis 199 
Sample size estimations were performed using G*Power software v3.1.9.4. Based on differences in 200 
plasma insulin following sleep deprivation (D=1.58), and considering the multi-level (i.e. 3 condition) 201 
design of the study a sample size of 30 was deemed adequate to provide a 95% chance of detecting 202 
such an effect at =0.05.  203 
All in text values are reported as means with normalised confidence intervals, unless otherwise stated. 204 
Normality of data was assessed using the Shapiro-Wilk test, with a paired t test or Wilcoxon’s test 205 
employed to analyse parametric data and non-parametric data respectively. A mixed model ANOVA 206 
(condition, time, and condition x time) was used to examine differences in blood glucose and insulin 207 
data, with post-hoc Bonferroni corrections applied in GraphPad Prism (GraphPad Software Inc., 208 
California, USA). Statistical significance was accepted at p < 0.05. Error bars shown on figures are 209 
also normalised confidence intervals (CI) corrected for between-participant variation, such that the 210 
magnitude of these CI’s therefore directly infers the contrast between paired means at each time-point 211 
rather than variance of individual values around the mean [19]. Using this approach, error bars not 212 
overlapping their respective comparison would typically be deemed significantly different according 213 
to conventional null hypothesis testing (i.e. p<0.05). Incremental area under the curve (iAUC – 214 
Trapezoid method [20]) and Matsuda Insulin sensitivity index (Matsuda index; [21]) were calculated 215 
from plasma glucose and insulin data using Microsoft excel (Version 16.04848.1000, Microsoft, 216 
Redmond, WA, USA). Updated homeostatic model of insulin resistance (HOMA2-IR; [22]) was 217 
calculated using publicly available online software (https://www.dtu.ox.ac.uk/homacalculator/). 218 
Distribution of the rs762551 SNP was tested for fit against the global expected distribution using a 219 
Pearson’s χ2 test with 1 degree of freedom. All values for genotype data were taken from the 220 
Fragmented+Coffee condition, with iAUC calculated as the difference between Fragmented+Coffee 221 
and Fragmented. As data for genotype was not paired, differences between means was compared 222 
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using standard 95% confidence intervals. Effects of trial order were assessed using two-way ANOVA 223 
testing for effects of Condition, Sequence, or Sequence x Condition interactions [23, 24]. 224 
Results 225 
Glycaemia, Insulinaemia, and Insulin Sensitivity 226 
Mixed model ANOVA revealed main effects for glucose for condition (p < 0.01), time (p < 0.01), 227 
and condition x time (p < 0.01).  Plasma glucose concentrations did not differ between conditions at 228 
baseline and remained similar prior to ingestion of the oral glucose load (i.e. following caffeine or 229 
hot water ingestion; Figure 1A). After ingestion of the oral glucose load, plasma glucose 230 
concentrations rose to a greater extent in the Fragmented+Coffee versus the Fragmented and Control 231 
conditions (8.61 [CI: 8.25-8.96] mmol∙L-1 versus 7.92 [CI: 7.57-8.28] mmol∙L-1, and 7.57 [CI: 7.21-232 
7.92] mmol∙L-1 respectively; p < 0.05). Plasma glucose concentration remained higher in the 233 
Fragmented+Coffee condition relative to Control and Fragmented conditions at 120-mins (p < 0.05). 234 
As such, plasma glucose incremental area under the curve (iAUC) was higher in the 235 
Fragmented+Coffee condition relative to the Fragmented (p = 0.02) but not Control (p > 0.05) 236 
Conditions (196.6 [175.4-217.7] versus 130.3 [114.3-146.4] versus 153.1 [137.0-169.1] mmol∙L-237 
1∙120min, respectively). 238 
Plasma insulin displayed effects of time (p < 0.01), but not condition (p = 0.06) or condition x time 239 
(p = 0.053). Baseline plasma insulin concentrations were similar between conditions pre-OGTT 240 
(Figure 1B). Following ingestion of the glucose load, insulin rose to a greater extent in the 241 
Fragmented+Coffee condition, relative to both Control and Fragmented conditions (272 [251-293] 242 
pmolL-1 vs 227 [206-248] pmol∙L-1 and 223 [202-244] pmol∙L-1) at 30-minutes (p < 0.05) (Figure 243 
1B). Plasma glucose incremental area under the curve (iAUC) was not different in the 244 
Fragmented+Coffee condition relative to the Fragmented (p = 0.06) and Control (p = 0.08) Conditions 245 
(10035 [8892-11178] versus 7837 [7260-8980] versus 8425 [7848-9001] pmol∙L-1∙120min, 246 
respectively. Time to peak insulin, HOMA2-IR and Matsuda insulin sensitivity index were not 247 
different between conditions (Table 2).  248 
Order effect 249 
Analysis of Sequence x Condition interactions revealed no effect of first trial on the observed effect 250 
of Fragmented+Coffee (p = 0.101). However, an order effect in plasma glucose iAUC was observed 251 
whereby values in participants first trial were higher than both the second and third trial (197.0 [173.4-252 
220.6] versus 147.5 [125.7-169.3] versus 132.2 [106.5-158.0] mmol∙L-1∙120 min).  253 
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Subjective Sleep Quality 254 
Time to sleep (Median [Inter Quartile Range]; 23:30 [23:00-00:00] h vs 23:30 [23:00-00:01] h, vs 255 
23:45 [23:05-24:10] h) and wake time (07:00 [06:52-07:17] h vs 07:00 [07:00-07:16] h vs 07:00 256 
[06:55-07:20] h) did not differ between Control, Fragmented and Fragmented+Coffee conditions, 257 
respectively. Subjective ratings of sleep fragmentation (i.e. “How fragmented was your night’s 258 
sleep?”) were greater in the Fragmented, and Fragmented+Coffee conditions, relative to the Control 259 
condition (83 [78-87] versus 81 [77-85] versus 8 [3-11] mm/100, respectively).  260 
Genotyping 261 
Of the n=26 genotyped, 15 participants were homozygous for the A allele, with the remaining 11 262 
carrying the C allele (n=2 CC; n=9 AC). The distribution of genotypes was therefore as expected 263 
within the given population and therefore did not deviate from the Hardy – Weinberg equilibrium 264 
(Pearson’s χ2 test with 1 df, P >0·05).  265 
Secondary Analysis: Glycaemia and insulinaemia by genotype. 266 
The glucose incremental area under the curve (iAUC - AA: 208.5 [95%CI: 126.2-290.8] versus 267 
AC/CC: 188.7 [95%CI: 103.9-273.4] mmol∙L-1∙120min; p = 0.54) and peak plasma glucose 268 
concentrations (AA: 8.86 [95%CI: 7.94-9.78] versus AC/CC: 9.13 [95%CI: 8.33-9.93] mmol∙L-1; p 269 
= 0.71) did not differ between “fast metaboliser” (AA) and “slow metaboliser” (AC/CC) genotype. 270 
Furthermore, ΔiAUC for glucose between the sleep fragmentation and coffee trials was similar 271 
between “fast” and “slow” genotypes respectively (81.8 [18.5-145.1] versus 55.7 [-8.1-119.4] 272 
mmol∙L-1∙120 min; p = 0.26).  273 
Similarly, peak insulin concentration (AA: 309.9 [220.7-399.1] versus AC/CC: 345.5 [283.7-407.4] 274 
pmol∙L-1; p = 0.84), insulin iAUC (AA: 10234.5 [6720.2-13748.8] versus AC/CC: 10842.9 [6558.2-275 
15127.7] pmol∙L-1∙120min; p = 0.80), and ΔiAUC for insulin did not differ between “fast metaboliser” 276 
or “slow metaboliser” genotype respectively (2680.3 [423.0-4937.6] versus 2047.8 [-3447.06-277 
7542.6] pmol∙L-1∙120min; p = 0.75).  278 
Discussion 279 
The current study demonstrates that one night of hourly sleep fragmentation had no effect on next-280 
day insulin sensitivity or glucose tolerance, relative to a habitual night of sleep, in young, healthy 281 
men and women. However, consumption of caffeinated coffee after sleep fragmentation increased 282 
glucose iAUC by ~50%.  283 
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A recent survey found that ~40% of people in the UK drink caffeinated coffee upon waking, and 284 
therefore the coffee condition in the current study provided an important ecological comparison to 285 
the sleep-fragmentation alone condition [8]. Previous studies have demonstrated acute reductions in 286 
glucose tolerance when caffeinated coffee is ingested prior to assessment of glucose metabolism [10]. 287 
In the present study, glucose iAUC was ~50% greater following caffeinated coffee relative to sleep 288 
fragmentation alone; this agrees with the one other study to have investigated the combination of 289 
caffeinated coffee and sleep disruption [16], albeit in the reverse order (i.e. caffeine before versus 290 
after sleep) and in relation to overall sleep deprivation (i.e. lower total duration) rather than the 291 
fragmentation reported here. Indeed, in that previous study there was no habitual sleep control 292 
condition and the caffeinated coffee was ingested during the sleep deprivation period; the present 293 
study therefore extends those findings by isolating the independent effects of sleep deprivation and 294 
caffeinated coffee, with the latter consumed following, rather than prior to sleep disruption.  295 
Whilst not investigated in the current study, there are several potential mechanisms following 296 
caffeinated coffee ingestion that may explain the reduction in glucose tolerance. Primarily, within a 297 
circulating range of 25-40 mmolL-1 caffeine acts as an antagonist for adenosine receptors, 298 
particularly in skeletal muscle where caffeine may inhibit glucose uptake via A1 adenosine receptor 299 
antagonism [25-27]. Additionally, caffeine ingestion is a stimulant for the release of adrenaline, 300 
which suppresses the action of insulin through β-adrenergic receptor activation [28-30]. It is also 301 
worth considering the lipolytic effects of caffeine ingestion on glucose uptake into skeletal muscle. 302 
The dose of caffeine provided in the current study is likely sufficient to induce lipolysis prior to the 303 
OGTT, subsequently impairing glucose uptake into the muscle [31, 32]. Finally, the role of cortisol 304 
in disruption of glucose metabolism must also be considered. Specifically, cortisol is elevated 305 
following both caffeine ingestion [33], and sleep disruption [3], which elevates postprandial glucose 306 
responses [34].  307 
The rate of caffeine metabolism is affected by the rs762551 single-nucleotide polymorphism in the 308 
CYP1A2 gene, with individuals classed as either fast (AA) or slow (AC/CC) metabolisers [35]. 309 
Recent evidence suggests that postprandial glycaemic and insulinaemic responses to both chronic and 310 
acute caffeine ingestion are modulated by this polymorphism [14]. Despite observing the expected 311 
distribution of the rs762551 SNP, no difference in the insulinaemic or glycaemic response to the 312 
glucose load was found between genotype following caffeinated-coffee ingestion. While this may 313 
suggest that the modulating effect of the rs762551 SNP was not present, this analysis was included 314 
on an exploratory basis and thus the study was not directly powered to detect differences between 315 
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“fast” and “slow” metabolisers. Future work should therefore investigate the acute effect of this SNP 316 
on the response to coffee both after a night of disrupted versus habitual sleep in a larger sample.   317 
The current study observed no difference in insulin sensitivity or glucose tolerance following sleep 318 
fragmentation relative to a habitual night of sleep. This is interesting considering that previous work 319 
has shown even a single night of sleep restriction is sufficient to induce reductions in both peripheral 320 
and hepatic insulin sensitivity relative to a habitual night of sleep [2]. In similar fashion to Gonnissen 321 
et al [6], the current study observed one time-point at which postprandial plasma insulin concentration 322 
was lower following Fragmented versus Control, which in the former was speculated to be due to a 323 
difference in night-time glycogen use from waking. However, this cannot be directly concluded from 324 
one time point alone. Speculatively, lack of postprandial differences in the current and previous study 325 
[6] may be explained by the total magnitude of sleep disruption achieved through hourly sleep 326 
fragmentation. In the current study, wake time was ~70-80 minutes total. Comparatively, Donga et 327 
al [2] employed a broken sleep protocol (i.e. sleep time 2300-0100 h and 0500-0730 h) in healthy 328 
lean subjects, observing a ~22% increase in endogenous glucose production alongside a ~20% 329 
decrease in the rate of glucose disposal, indicative of reduced hepatic and peripheral insulin 330 
sensitivity, respectively. Similarly, two nights of sleep reduction (~50% of habitual sleep duration: 331 
442 ± 78 min versus 235 ± 34 min) also reduced Matsuda insulin sensitivity index by ~19% relative 332 
to habitual sleep [4]. The total duration of sleep loss accumulated over one or more nights may 333 
therefore be proportionate to the effect on postprandial glycaemia. Speculatively, this could be 334 
explained by lesser disruption of slow-wave sleep (SWS - i.e. stage III of non-rapid eye movement 335 
sleep) with the current protocol compared to previous studies. As SWS is thought to be the most 336 
important mediator of metabolic, hormonal, and neurophysiological changes during sleep, studies 337 
observing greater reductions in insulin sensitivity are likely to have done so through employment of 338 
sleep disruption protocols that provide a greater degree of disruption to SWS [2, 4, 36]. Conversely 339 
in the current study, participants were aroused from sleep every hour, which based on the average 340 
length of each stage of sleep (~5-15 mins) and one sleep cycle (~90-110 mins) would potentially not 341 
provide as much SWS disruption as previous literature [37].  342 
Whilst the dose of caffeine ingested in the current is above that typically consumed in one cup of 343 
coffee on a daily basis (~100-200 mg) [38, 39], studies employing lower doses (~60 mg) have 344 
observed disrupted glucose control [10]. Despite this, a strength of the current study is the perhaps 345 
more ecologically valid model of consumption following one night of sleep curtailment relative to 346 
previous research [16]. Furthermore, the effects shown in this study are present in a relatively large 347 
sample size for an acute study of this nature. One potential limiting factor in the interpretation of the 348 
present results is the apparent order effect whereby mean plasma iAUC was higher in participants 349 
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first trial compared to both the second and third trials (197 [173-221] versus 148 [126-169] versus 350 
132 [106-158] mmolL-1, respectively). However, repeated measures ANOVA revealed no interaction 351 
effect between which trial participants performed first and the effect of Coffee on postprandial 352 
glycaemia relative to Fragmented and habitual sleep. Simply put, the higher responses in the 353 
Fragmented+Coffee condition were not due to the participants who performed the 354 
Fragmented+Coffee trial first. Furthermore, the addition of a 4th condition (i.e. habitual sleep+coffee) 355 
to the study would have provided an interesting comparison to fully assess the independent effects of 356 
caffeinated coffee relative to sleep disruption. The lack of assessment of hormones potentially linked 357 
to the mechanism of disruption (e.g. cortisol) also limit further discussion surrounding the effects 358 
reported. Finally, the current study also did not strictly control for the menstrual phase in female 359 
participants and this may have influenced our primary outcomes [40].  360 
In summary, no effect of hourly fragmented sleep (totalling <80 mins) was found on postprandial 361 
glucose and insulin responses to breakfast the next morning. However, the common approach of 362 
consuming a strong caffeinated coffee following disrupted sleep resulted in a reduction in insulin 363 
sensitivity and glucose tolerance. Following a night of disrupted sleep, individuals should balance the 364 
potential stimulating benefits of caffeinated coffee consumption with the potential to increase 365 
postprandial glucose excursions. 366 
Acknowledgements 367 
Thank you to the participants of this study for volunteering their time and effort. Further thanks are 368 
to be given to the 2018/19 cohort enrolled in the HL30054 Nutrition and Metabolism unit for their 369 
assistance with data collection.  370 
Conflict of interest 371 
None of the authors have any conflicts of interest to declare. 372 
Author contributions 373 
HAS –Design, data collection, analysis, write up 374 
AH – Data collection, analysis, write up 375 
JT – Data collection, write up 376 
JPW – Analysis, write up 377 
PH – Data collection, write up 378 
OP – Data collection, write up 379 
YCC – Data collection, write up 380 
JGT – Design, data collection, write up 381 






1. Briancon-Marjollet, A., et al., The impact of sleep disorders on glucose metabolism: 386 
endocrine and molecular mechanisms. Diabetol Metab Syndr, 2015. 7: p. 25. 387 
2. Donga, E., et al., A single night of partial sleep deprivation induces insulin resistance in 388 
multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab, 2010. 95(6): p. 389 
2963-8. 390 
3. Stamatakis, K.A. and N.M. Punjabi, Effects of sleep fragmentation on glucose metabolism in 391 
normal subjects. Chest, 2010. 137(1): p. 95-101. 392 
4. Sweeney, E.L., et al., Skeletal muscle insulin signaling and whole-body glucose metabolism 393 
following acute sleep restriction in healthy males. Physiol Rep, 2017. 5(23). 394 
5. Wang, X., et al., Short-Term Moderate Sleep Restriction Decreases Insulin Sensitivity in 395 
Young Healthy Adults. Sleep Health, 2016. 2(1): p. 63-68. 396 
6. Gonnissen, H.K., et al., Effects of sleep fragmentation on appetite and related hormone 397 
concentrations over 24 h in healthy men. Br J Nutr, 2013. 109(4): p. 748-56. 398 
7. Tamaki, M., et al., Night Watch in One Brain Hemisphere during Sleep Associated with the 399 
First-Night Effect in Humans. Curr Biol, 2016. 26(9): p. 1190-4. 400 
8. Statista. Why do you usually drink coffee? 2017  February 14, 2019.]; Available from: 401 
https://www.statista.com/statistics/681692/coffee-consumption-drivers-united-kingdom-uk/. 402 
9. Poole, R., et al., Coffee consumption and health: umbrella review of meta-analyses of 403 
multiple health outcomes. Bmj, 2017. 359: p. j5024. 404 
10. Moisey, L.L., L.E. Robinson, and T.E. Graham, Consumption of caffeinated coffee and a 405 
high carbohydrate meal affects postprandial metabolism of a subsequent oral glucose 406 
tolerance test in young, healthy males. Br J Nutr, 2010. 103(6): p. 833-41. 407 
11. Robertson, T.M., et al., A single serving of caffeinated coffee impairs postprandial glucose 408 
metabolism in overweight men. Br J Nutr, 2015. 114(8): p. 1218-25. 409 
12. Sachse, C., et al., Functional significance of a C-->A polymorphism in intron 1 of the 410 
cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol, 1999. 47(4): p. 411 
445-9. 412 
13. Thorn, C.F., et al., PharmGKB summary: caffeine pathway. Pharmacogenet Genomics, 413 
2012. 22(5): p. 389-95. 414 
14. Robertson, T.M., et al., Postprandial glycaemic and lipaemic responses to chronic coffee 415 
consumption may be modulated by CYP1A2 polymorphisms. Br J Nutr, 2018. 119(7): p. 416 
792-800. 417 
15. Banks, N.F., et al., Genetic Polymorphisms in ADORA2A and CYP1A2 Influence Caffeine's 418 
Effect on Postprandial Glycaemia. Sci Rep, 2019. 9(1): p. 10532. 419 
16. Rasaei, B., et al., Simultaneous coffee caffeine intake and sleep deprivation alter glucose 420 
homeostasis in Iranian men: a randomized crossover trial. Asia Pac J Clin Nutr, 2016. 421 
25(4): p. 729-739. 422 
17. Bell, D.G. and T.M. McLellan, Exercise endurance 1, 3, and 6 h after caffeine ingestion in 423 
caffeine users and nonusers. J Appl Physiol, 1985. 93(4): p. 1227-34. 424 
18. Rimm, E.B., et al., Validity of self-reported waist and hip circumferences in men and 425 
women. Epidemiology, 1990. 1(6): p. 466-73. 426 
19. Loftus, G.R. and M.E. Masson, Using confidence intervals in within-subject designs. 427 
Psychon Bull Rev, 1994. 1(4): p. 476-90. 428 
20. Wolever, T.M.S., Effect of blood sampling schedule and method of calculating the area 429 
under the curve on validity and precision of glycaemic index values. British Journal of 430 
Nutrition, 2004. 91(2): p. 295-300. 431 
21. Matsuda, M. and R.A. DeFronzo, Insulin sensitivity indices obtained from oral glucose 432 
tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 1999. 433 
22(9): p. 1462-70. 434 
13 
 
22. Levy, J.C., D.R. Matthews, and M.P. Hermans, Correct homeostasis model assessment 435 
(HOMA) evaluation uses the computer program. Diabetes Care, 1998. 21(12): p. 2191-2. 436 
23. Wellek, S. and M. Blettner, On the proper use of the crossover design in clinical trials: part 437 
18 of a series on evaluation of scientific publications. Dtsch Arztebl Int, 2012. 109(15): p. 438 
276-81. 439 
24. Betts, J.A., et al., PRESENT 2020: Text Expanding on the Checklist for Proper Reporting of 440 
Evidence in Sport and Exercise Nutrition Trials. Int J Sport Nutr Exerc Metab, 2020. 15: p. 441 
1-12. 442 
25. Thong, F.S. and T.E. Graham, Caffeine-induced impairment of glucose tolerance is 443 
abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol, 1985. 92(6): p. 444 
2347-52. 445 
26. Fredholm, B.B., Astra Award Lecture. Adenosine, adenosine receptors and the actions of 446 
caffeine. Pharmacol Toxicol, 1995. 76(2): p. 93-101. 447 
27. Vergauwen, L., P. Hespel, and E.A. Richter, Adenosine receptors mediate synergistic 448 
stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal 449 
muscle. J Clin Invest, 1994. 93(3): p. 974-81. 450 
28. Avogaro, A., et al., Epinephrine exerts opposite effects on peripheral glucose disposal and 451 
glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test 452 
minimal model study. Diabetes, 1996. 45(10): p. 1373-8. 453 
29. Baron, A.D., P. Wallace, and J.M. Olefsky, In vivo regulation of non-insulin-mediated and 454 
insulin-mediated glucose uptake by epinephrine. J Clin Endocrinol Metab, 1987. 64(5): p. 455 
889-95. 456 
30. Deibert, D.C. and R.A. DeFronzo, Epinephrine-induced insulin resistance in man. J Clin 457 
Invest, 1980. 65(3): p. 717-21. 458 
31. Kovacs, E.M., J. Stegen, and F. Brouns, Effect of caffeinated drinks on substrate 459 
metabolism, caffeine excretion, and performance. J Appl Physiol (1985), 1998. 85(2): p. 460 
709-15. 461 
32. Gonzalez, J.T., Paradoxical second-meal phenomenon in the acute postexercise period. 462 
Nutrition, 2014. 30(9): p. 961-7. 463 
33. Lovallo, W.R., et al., Caffeine stimulation of cortisol secretion across the waking hours in 464 
relation to caffeine intake levels. Psychosom Med, 2005. 67(5): p. 734-9. 465 
34. De Feo, P., et al., Contribution of cortisol to glucose counterregulation in humans. Am J 466 
Physiol, 1989. 257(1 Pt 1). 467 
35. Yang, A., A.A. Palmer, and H. de Wit, Genetics of caffeine consumption and responses to 468 
caffeine. Psychopharmacology, 2010. 211(3): p. 245-57. 469 
36. Tasali, E., et al., Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad 470 
Sci U S A, 2008. 105(3): p. 1044-9. 471 
37. Roebuck, A., et al., A review of signals used in sleep analysis. Physiol Meas, 2014. 35(1): p. 472 
R1-57. 473 
38. Desbrow, B., et al., An examination of consumer exposure to caffeine from retail coffee 474 
outlets. Food Chem Toxicol, 2007. 45(9): p. 1588-92. 475 
39. Ludwig, I.A., et al., Coffee: biochemistry and potential impact on health. Food Funct, 2014. 476 
5(8): p. 1695-717. 477 
40. Valdes, C.T. and K.E. Elkind-Hirsch, Intravenous glucose tolerance test-derived insulin 478 






















Table 1. Summary of Participant Characteristics.  499 
 Male (n=16) Female (n=13) Combined (n=29) 
Age (y) 22 ± 1 21 ± 1 21 ± 1 
Height (m) 1.81 ± 0.07 1.69 ± 0.07 1.78 ± 0.09  
Body mass (kg) 82.2 ± 10.5 66.3 ± 11.5 75.3 ± 13.47 
Body Mass Index (kg·m-2) 25.0 ± 2.6 23.2 ± 3.8 24.2 ± 3.3 
Waist circumference (cm) 84.0 ± 6.4 73.3 ± 8.2 80.4 ± 8.7  
Hip circumference (cm) 100.7 ± 6.8 97.1 ± 12.9 99.1 ± 10.0 
Waist:Height (cm) 0.46 ± 0.03 0.43 ± 0.05 0.45 ± 0.04 









































Table 2. Peak and time to peak glucose and insulin values in each condition alongside Matsuda 539 
insulin sensitivity index. Values are mean [normalised confidence interval]. 540 
 Control Fragmented Fragmented+Coffee 
Peak Glucose (mmolL-1) 
 
8.20 [7.93-8.47] 8.23 [7.96-8.50] 8.96 [8.70-9.22]* 
Peak Insulin (pmolL-1) 
 
265.1 [247.3-283.0] 235.4 [217.6-253.3] 310.5 [283.5-337.4]* 
Time to Peak Glucose 
(min) 
33 [29-36] 28 [25-32] 30 [27-33] 
Time to Peak Insulin 
(min) 
36 [32-40] 35 [31-38] 38 [35-42] 
ISI Matsuda (au) 
 
15.4 [14.3-16.3] 15.3 [14.2-16.3] 13.9 [12.9-14.9] 
HOMA2-IR (au) 0.40 [0.26-0.54] 0.55 [0.41-0.68] 0.43 [0.28-0.58] 































Figure 1. A) Time course plasma glucose and B) Time course plasma insulin response to an oral 570 
glucose load following a habitual night of sleep (Control), a night of fragmented sleep (Fragmented), 571 
or sleep fragmentation + caffeinated coffee (Fragmented + Coffee). *p < 0.05 572 
 573 
